The current valuation score of Ovid Therapeutics Inc is 8.07, ranking 129 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -10.24, which is -94.26% below the recent high of -0.59 and -26.13% above the recent low of -12.91.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.